Josh is the global chair of Cooley’s digital health group and serves on Cooley’s Life Sciences Advisory Board. He represents life sciences and technology clients through the full company life cycle, from seed stage through private financings, mergers & acquisitions, and initial public offerings. He also regularly advises his clients on general corporate issues, securities matters and implications of proposed business transactions. In the past five years, Josh has handled 350+ venture capital financings with an aggregate deal value of more than $5 billion, including more than $2 billion in the past year. Josh counsels clients across industries including companies operating in the biotechnology, therapeutics, pharma, climate tech and energy, digital health, medical technology and software sectors. Josh previously worked in the healthcare industry at Practice Fusion, a web-based electronic health record company where he was corporate counsel and director of business development. In this role, he was responsible for generating revenue, leading the company through complex regulations governing digital healthcare and records, negotiating contracts, and more.